DNLI insiders

19 insiders have filed at DNLI since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Baker Bros. Advisors LpDirector3.41M1.825%
Baker Bros. Advisors (gp) LlcDirector3.41M1.825%
Baker FelixDirector3.41M1.825%
Baker JulianDirector3.41M1.825%
667, L.P.Director3.41M1.825%
Baker Brothers Life Sciences LpDirector3.41M1.825%
Watts Ryan J.President And CEO2.45M1.312%11 sells $10.7M
Tessier-Lavigne MarcDirector2.12M1.138%
Krognes Steve E.Director813.6k0.436%11 sells $4.3M
Schuth Alexander O.Cofo And Secretary806.6k0.432%20 sells $2.8M
Flatley Jay TDirector352.5k0.189%
Ho CaroleChief Medical Officer241.6k0.129%16 sells $1.6M
Sato Vicki LDirector108.0k0.058%20 sells $748k
Schenkein David PDirector46.5k0.025%2 sells $1.9M
Klein Peter SDirector27.5k0.015%
Cook Jennifer E.Director26.1k0.014%1 sells $32k
Thornberry NancyDirector24.7k0.013%
Harris ErikDirector17.1k<0.01%
Van Hauwermeiren TimothyDirector10.6k<0.01%

Full register at boothcheck.com/insiders/DNLI. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

DNLI institutional holders · DNLI research report